Literature DB >> 874695

Intrapatient variability in theophylline kinetics.

P D Walson, R C Strunk, L M Taussig.   

Abstract

Seven asthmatic children had repeat determinations of theophylline pharmacokinetic measurements over three- to nine-month intervals. Significant intrapatient variability was found in the theophylline clearance and t1/2, which determine the dosage regimen necessary to provide given average, peak, and trough theophylline plasma levels. Repeat clearance values were, on average, 52% different from the original clearances, with a range of -57% to +142%. A single determination of theophylline kinetic measurements in any individual patient cannot be used routinely to predict future theophylline dosage regimens for that patient.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874695     DOI: 10.1016/s0022-3476(77)80844-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Evaluation of the utility of a proposed method for correcting for intrasubject variability in metabolic clearance in the bioavailability assessment of theophylline.

Authors:  Y Kasuya; T Furuta; H Shibasaki; H Shimota
Journal:  J Pharmacokinet Biopharm       Date:  1991-02

2.  Current state of theophylline in asthma.

Authors:  S McKenzie
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

Review 3.  Clinical pharmacokinetics of theophylline.

Authors:  R I Ogilvie
Journal:  Clin Pharmacokinet       Date:  1978 Jul-Aug       Impact factor: 6.447

4.  The effect of assay methods on plasma levels and pharmacokinetics of theophylline: HPLC and EIA.

Authors:  T Ishizaki; M Watanabe; N Morishita
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

5.  New method for bioavailability assessment of slow-release preparations of theophylline.

Authors:  Y Kasuya; T Ohno; N Kubota; H Takahashi; H Hirayama
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

6.  Greatly enhanced bioavailability of theophylline on postprandial administration of a sustained release tablet.

Authors:  M Lagas; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Once a day theophylline; serum concentrations.

Authors:  V Nerminathan; S A McKenzie
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

8.  Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults.

Authors:  R A Upton; J F Thiercelin; T W Guentert; S M Wallace; J R Powell; L Sansom; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

9.  Outpatient theophylline determinations.

Authors:  A R Knodel; H D Covelli; J F Beekman
Journal:  West J Med       Date:  1984-05

10.  Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method.

Authors:  J H Wilkens; H Neuenkirchen; G W Sybrecht; M Oellerich
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.